Key Financial Data Of Group

Chordia Therapeutics,Inc - Filing #7267458

Concept As at
2025-02-28
2024-09-01 to
2025-02-28
2023-09-01 to
2024-08-31
As at
2024-08-31
As at
2024-02-29
2023-09-01 to
2024-02-29
Key financial data of group
Business results of group
Ordinary profit (loss)
-975,131,000 JPY
-1,824,707,000 JPY
-801,401,000 JPY
Net assets
3,246,536,000 JPY
4,161,297,000 JPY
3,698,270,000 JPY
Total assets
3,451,515,000 JPY
4,632,370,000 JPY
3,902,398,000 JPY
Basic earnings (loss) per share
-14.31
-31.11
-14.22
Diluted earnings per share
Equity-to-asset ratio
0.940 xbrli:pure
0.898 xbrli:pure
0.941 xbrli:pure
Net cash provided by (used in) operating activities
-1,114,470,000 JPY
-1,937,248,000 JPY
-1,052,483,000 JPY
Net cash provided by (used in) investing activities
-667,000 JPY
-10,959,000 JPY
-178,000 JPY
Net cash provided by (used in) financing activities
61,580,000 JPY
1,478,797,000 JPY
JPY
Cash and cash equivalents
3,276,066,000 JPY
4,329,624,000 JPY
3,746,373,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.